Sumitomo Chemical raised its consolidated earnings outlook for the fiscal year ending March 2027 across 3 items: revenue, operating profit and net profit. The improvement in performance at its Saudi joint venture was cited as a factor behind the revision.
Sumitomo Chemical raised its consolidated earnings outlook for the fiscal year ending March 2027 across 3 items: revenue, operating profit and net profit.
The improvement in performance at its Saudi Arabian joint venture was reported to have contributed to the revision.
Although the body does not state the size of the revisions or specific figures, it reports that the outlook for each item was raised.